Nestled in the heart of Green Bay, Wisconsin, avIVa Infusions is a ray of hope for individuals grappling with chronic pain or persistent mood disorders that have not been responsive to traditional treatments. This wellness sanctuary, expertly helmed by medical veterans Julie and Ellen, offers innovative ketamine infusion therapy to help manage conditions such as depression, anxiety, migraines, and complex regional pain syndrome. Their near two-decade experience in anesthesiology infuses their practice with unparalleled professionalism. Motivated by a fervent desire to help people conquer chronic health difficulties, the avIVa team is committed to refurbishing patients' lives and offering renewed vitality through Harnessing the transformative power of ketamine therapy.

Your journey with avIVa Infusions commences with a comprehensive consultation where either Ellen or Julie delve into your medical and mental health history, meticulously preparing a suitable treatment plan. The team ensures all your queries are satisfactorily answered to set the stage for the subsequent treatments. Scheduled to last about an hour and a half, the therapy sessions find an ideal balance between comfort and efficacy – the mood therapy ketamine infusion is around 40 minutes, while the chronic pain treatment extends from 2 to 4 hours. The meticulously designed treatment rooms are equipped with adjustable lights and a white noise machine to curate a soothing ambiance. There are provisioned earplugs, or patients could opt to bring their own favorite music. While some may experience minor hallucinations or out-of-body sensations during the process, these symptoms recede promptly post-infusion. Constant monitoring by adept staff enhances safety during the treatment and patients are required to arrange for a ride home post-procedure. At Aviva Infusions, the aim is to be more than a fleeting medical intervention – they offer ongoing daily support as you chart a path through your health journey. Particularly beneficial for those adversely affected by treatment-resistant conditions, Aviva's pioneering ketamine therapy is proving to be a refreshing alternative to conventional health interventions.